Anemia of Chronic Disease
8
0
0
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
25.0%
2 terminated out of 8 trials
60.0%
-26.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia
Anemia of Inflammation and Deficiency Anemia
Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney Disease
A Phase 2A Trial of FMX-8 Treatment for Anemia in Patients With ESRD on Hemodialysis HD
Pharmacokinetics/Pharmacodynamics of NOX-H94 in the Human Endotoxemia Model
Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Cancer
An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic Disease